Old Web
English
Sign In
Acemap
>
authorDetail
>
Xue Gai
Xue Gai
Janssen Pharmaceutica
Bortezomib
Internal medicine
Medicine
Dexamethasone
Daratumumab
3
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Chinese Patients with Relapsed or Refractory Multiple Myeloma: Phase 3 LEPUS (MMY3009) Study.
2021
Clinical Lymphoma, Myeloma & Leukemia
Jin Lu
Weijun Fu
Wei Li
Jianda Hu
Gang An
Yafei Wang
Chengcheng Fu
Lijuan Chen
Jie Jin
Xinan Cen
Zheng Ge
Zhen Cai
Ting Niu
Ming Qi
Steven Sun
Xue Gai
Weiping Liu
Wenyu Liu
Xue Yang
Xiao-Jun Huang
Show All
Source
Cite
Save
Citations (1)
Daratumumab, bortezomib, and dexamethasone versus bortezomib and dexamethasone in Chinese patients with relapsed or refractory multiple myeloma: phase 3 LEPUS (MMY3009) study
2021
Clinical Lymphoma, Myeloma & Leukemia
Jin Lu
Weijun Fu
Wei Li
Jianda Hu
Gang An
Yafei Wang
Chengcheng Fu
Lijuan Chen
Jie Jin
Xinan Cen
Zheng Ge
Zhen Cai
Ting Niu
Ming Qi
Steven Sun
Xue Gai
Weiping Liu
Wenyu Liu
Xue Yang
Xiao-Jun Huang
Show All
Source
Cite
Save
Citations (0)
Daratumumab, Bortezomib, Dexamethasone (D-Vd) Versus Bortezomib and Dexamethasone (Vd) in Relapsed or Refractory (RR) Multiple Myeloma (MM): Pooled Subgroup Analysis of Lepus and Castor
2020
Blood
Jin Lu
Weijun Fu
Wei Li
Jianda Hu
Gang An
Yafei Wang
Chengcheng Fu
Lijuan Chen
Jie Jin
Xi-Nan Cen
Zheng Ge
Zhen Cai
Ting Niu
Andrew Spencer
Katja Weisel
Maria-Victoria Mateos
Ajay K. Nooka
Ming Qi
Steven Sun
Xue Gai
Weiping Liu
Xue (Loya) Yang
Xiao-Jun Huang
Show All
Source
Cite
Save
Citations (0)
1
map